Delivering Simplified Injectable Medicine

Pirouette develops OnePush, a disc‑shaped, push‑button auto‑injector with a fully automatic, hidden needle and smooth, controlled insertion engineered to reduce needle sensation and hesitation during home use. The platform is API‑agnostic and partner‑ready, enabling Pirouette's own programs and co‑development with pharmaceutical companies to place novel and established injectables for chronic conditions—such as oncology therapies and HIV medications—into a preferred device experience that supports patient compliance and persistency at scale.

OnePush turns patient comfort into adherence — and your injectable into a stronger brand.

OnePush is designed to improve brand differentiation and adoption, strengthen patient preference and loyalty, and raise compliance and persistency by delivering hidden‑needle comfort for home administration. In fact, blinded market research shows that 100% of oncologists would prescribe OnePush over traditional auto-injectors, recognizing its ability to reduce anxiety and improve ease of use. By dramatically reducing both needle visibility and sensation, Pirouette aims to empower patients to reliably and persistently self-administer essential medications for chronic disease, ultimately improving health outcomes and quality of life.

Learn More

Our mission

Pirouette is committed to reimagining the delivery of injectable medicines by focusing on patient comfort and confidence through intuitive design. The goal is simple: help people start and stay on chronic injectable therapies while giving our partners a device driven advantage.

Learn More

Platform

We apply engineering to drug delivery. Our disc-shaped, push-button auto-injector is built for high-stress use, with a hidden needle and controlled insertion. We pair it with well-known medicines and build on existing FDA data to speed development. The result: precise intramuscular or subcutaneous dosing and a platform that helps patients adhere to prescribed dosing schedules.

Learn More

Pipeline

Pirouette Pharma is developing improved presentations of multiple well-characterized injectable medicines using the FDA's 505(b)(2) and 351(k) pathways.

Get in touch

Reach out to learn more about Pirouette Pharma and explore partnerships.

Contact